M Leblanc. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AgedAnti-Infective Agents/therapeutic useBacterial Infections/drug therapyCiprofloxacin/therapeutic useEscherichia coliEscherichia coli Infections/drug therapyFemaleHumansKlebsiella Infections/drug therapyKlebsiella pneumoniaeMaleMiddle AgedPeritoneal Dialysis, Continuous Ambulatory/adverse effectsPeritonitis/drug therapyPeritonitis/microbiologySerratia Infections/drug therapySerratia marcescens
Substances： See more » Anti-Infective AgentsCiprofloxacin
Year: 1997 PMID： 9181286
Source DB: PubMed Journal: Clin Nephrol ISSN： 0301-0430 Impact factor: 0.975